Monday 19 October 2026 captured the state of Australian public M&A with ASX-listed Cleanaway Waste Management announcing a binding scheme implementation deed with EQT Infrastructure at an implied enterprise value of about A$9.3 billion and ASX-listed Challenger disclosing a non-binding A$11.80 per share proposal from TAL Daiichi Life Australia. Media reports put the day's total announced activity at roughly A$22.4 billion with market data showing foreign takeovers of ASX-listed companies up more than 200% in the first nine months of 2026.
The targets, however, are very different businesses: one collects garbage, the other sells retirement income. What they share is what bidders want most in the current economy –long-dated, predictable and inflation-resilient cash flows.
In a challenging economic environment, an essential service with contracted customers or a book of annuity liabilities backed by a scaled investment platform, is worth more to private capital than the share market will pay for it.
That gap is the opportunity. It is also the source of tension. Target shareholders, and increasingly the wider public, expect a fair share of that value. A bidder that does not pay it or takes a Scrooge-like approach to paying it may not bag the deal.
Cleanaway: paying a full price
EQT first made an unsolicited, non-binding proposal at A$3.00 per share. It then raised its offer to A$3.13 (a 32.1% premium). Only after that increase did the Cleanaway board grant up to nine weeks of exclusive due diligence and state its intention to recommend the bid.
The process was built around price certainty. During exclusivity, EQT gave repeated written confirmations (on 14 September, 28 September, 4 and 11 October) that it remained committed to proceeding at no less than the indicative price and exclusivity was extended to 19 October to allow it to finish.
A private equity owner taking a national essential-services provider off the ASX operates under public scrutiny. A clear premium, a recommended process and credible price commitments are what made the deal viable.
Challenger: the strategic partner who must still pay for control
Challenger is Australia's largest annuities provider.
Daiichi Life's path to its proposal was gradual - acquiring an initial 15.1% stake and growing that interest to 20.5%, to become Challenger's largest shareholder and a commercial partner.
On 16 October 2026, Daiichi Life proposed acquiring the remaining 79.5% by scheme at A$11.80 cash, a 19.8% premium above the prior close, valuing Challenger at roughly A$7.8 to A$7.9 billion.
On 26 October, the board said the offer was ‘not at a level it could recommend to shareholders’ but that it intended to engage with its highly-valued, largest shareholder and commercial partner.
A bidder that already holds a blocking stake and a commercial relationship knows the business well and it may believe it is the natural owner.
On the other hand, minority shareholders will ask a simple question: why should a partner that already benefits from the relationship acquire the annuity franchise at a discount to its long-term value?
An existing stakeholder in a scheme also faces structural constraints. Its shares are likely to be voted in a separate class or excluded from the scheme vote, so the decision rests with the remaining holders.
Social licence as a pricing constraint
In Australian public M&A, social licence is not a soft concept. It works through specific mechanisms, including:
- Scheme voting thresholds
A scheme needs approval by 75% of votes cast and a majority in number of voting members (subject to the court's discretion). Organised institutional opposition can defeat an under-priced deal while a large, unhappy retail base can trigger regulatory, political and media scrutiny.
- Board recommendation and the independent expert
Boards are unlikely to recommend, or grant exclusivity, without a price they can defend. Defensibility depends not only on nuanced doctrines of law (directors’ duties) and corporate finance (valuation methodology), but is also subjected to subsequent testing by an independent expert report. The expert's ‘fair and reasonable’ opinion is the public measure of the transaction price.
- Regulatory approval including FIRB for foreign bidders
Foreign bidders need FIRB approval, and national interest considerations become more prominent for annuity returns. A bid that appears opportunistic gives critics an argument - a well-priced bid can remove a lot of the sting.
- Political and media scrutiny
Concern about the shrinking ASX and growing offshore ownership means bidders must explain why the transaction is good for members and for Australia.
With the value of annuity-style cash flows realised over decades, paying enough is commercially rational not a concession.
Permanence comes at a price
Demand for annuity-style revenue will continue while capital seeks long-dated returns and bidders look offshore for growth.
Australia's superannuation system, essential-services businesses and strong governance make it an attractive market. Bidders that succeed will need to recognise the value of permanence has to be shared.
Read More In This Edition
Going, going, gone: running an auction for a public M&A deal
Contests have been a defining feature of public M&A in 2026 and listed targets are increasingly running a competitive auction process to drive up the offer price.
19 November 2026
To vote or not to vote? Voluntary shareholder approval in Public-Listed M&A
Shareholder approval requirements for ASX-listed companies are back in the spotlight.
19 November 2026
The truth’s in the detail, so is the dividend
‘Truth-in-takeovers’ requires bidders, targets and substantial shareholders to stand behind public statements made as part of proposed control transactions.
19 November 2026
Public M&A market on a page: January - October 2026
Public M&A activity remains concentrated in large transactions and the Metals & Mining sector, while completion periods have increased materially.
19 November 2026
